These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11044823)

  • 1. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
    Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
    Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed cutaneous reaction to unfractionated heparin, low molecular weight heparin and danaparoid.
    Sivakumaran M; Ghosh K; Munks R; Gelsthorpe K; Tan L; Wood JK
    Br J Haematol; 1994 Apr; 86(4):893-4. PubMed ID: 7802799
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
    Ludwig RJ; Beier C; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of low molecular weight heparins by dermatologists].
    Maakaroun A; Gruel Y
    Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A; Fritsch P; Reider N
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed intracutaneous test reaction in heparin intolerance].
    Wurpts G; Merk HF
    Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
    Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
    Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
    Taylor AA
    BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Counsell C; Sandercock P
    Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
    Ramakrishna R; Manoharan A; Kwan YL; Kyle PW
    Br J Haematol; 1995 Nov; 91(3):736-8. PubMed ID: 8555084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 15. Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
    Blickstein D; Hod M; Bar J
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):765-8. PubMed ID: 14614358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombopenia increased by heparin and danaparoid].
    Godet G; Bertrand M; Van de Steen E; Boccara G; Koskas F
    Ann Fr Anesth Reanim; 2001 Jan; 20(1):50-3. PubMed ID: 11234580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative review of the adverse effect profiles of heparins and heparinoids.
    Borris LC; Lassen MR
    Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
    Seitz CS; Brocker EB; Trautmann A
    Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.